Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.9601
-0.08-7.68%
At close: -
$1.09
0.1313.53%
After Hours: Jun 13, 8:46 AM EDT
Comments
Loading...
Prelude Therapeutics Stock Price, Quotes and Forecasts
PRLDNASDAQ
Prelude Therapeutics (PRLD) Forecast
NewsEarningsPrelude Therapeutics (PRLD) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Prelude Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:PRLD | Benzinga
Explore Prelude Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PRLD.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Prelude Therapeutics (PRLD) stock?
You can purchase shares of Prelude Therapeutics (NASDAQ:PRLD) through any online brokerage.
Who are Prelude Therapeutics (PRLD) competitors?
Other companies in Prelude Therapeutics’s space includes: Renovaro (NASDAQ:RENB), Serina Therapeutics (AMEX:SER), Skye Bioscience (NASDAQ:SKYE), Fortress Biotech (NASDAQ:FBIO) and Adverum Biotechnologies (NASDAQ:ADVM).
What is the forecast, or price target, for Prelude Therapeutics (PRLD) stock?
Prelude Therapeutics has a consensus price target of $5.29.
What is the current price for Prelude Therapeutics (PRLD)?
The stock price for Prelude Therapeutics (NASDAQ: PRLD) is $1.09 last updated June 13, 2025 at 8:46 AM EDT.
Does Prelude Therapeutics (PRLD) pay a dividend?
There are no upcoming dividends for Prelude Therapeutics.
When is Prelude Therapeutics (NASDAQ:PRLD) reporting earnings?
Prelude Therapeutics’s Q2 earnings are confirmed for Monday, August 11, 2025.
Is Prelude Therapeutics (PRLD) going to split?
There is no upcoming split for Prelude Therapeutics.
What sector and industry does Prelude Therapeutics (PRLD) operate in?
Prelude Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
